VEGFA and glioblastoma: Accordingly, adding VEGFA inhibitors or multi-kinase inhibitors such as Sunitinib simultaneously with HIF inhibitor in clinical trials may well suppress angiogenesis of glioblastoma, slow tumor progression, and achieve improved OS.